Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Incidence of Cataract Surgery in Patients Treated with Mirvetuximab Soravtansine: An Evaluation of Ocular Safety

  • By

  • Jordyn F. Silverstein

  • Alexandra Smick

  • Edmund Tsui

  • Oladunni Alomaja

  • Bridget Johnson

  • Chi-Hong Tseng

  • Ritu Salani

  • Dennis J. Slamon

  • Dana M. Chase

  • Gottfried E. Konecny

  • May 21, 2026

Share

Clinical Scorecard: Incidence of Cataract Surgery in Patients Treated with Mirvetuximab Soravtansine: An Evaluation of Ocular Safety

At a Glance

CategoryDetail
Condition
Key MechanismsPotential intraocular inflammation due to FRα expression; corticosteroid eye drops may contribute to cataract formation, but further research is needed.
Target Population
Care Setting

Key Highlights

  • additional_context

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • R
      • e
      • g
      • u
      • l
      • a
      • r
      • e
      • y
      • e
      • e
      • x
      • a
      • m
      • i
      • n
      • a
      • t
      • i
      • o
      • n
      • s
      • e
      • v
      • e
      • r
      • y
      • 3
      • -
      • 6
      • m
      • o
      • n
      • t
      • h
      • s
      • f
      • o
      • r
      • p
      • a
      • t
      • i
      • e
      • n
      • t
      • s
      • o
      • n
      • M
      • I
      • R
      • V
      • t
      • o
      • a
      • s
      • s
      • e
      • s
      • s
      • f
      • o
      • r
      • c
      • a
      • t
      • a
      • r
      • a
      • c
      • t
      • d
      • e
      • v
      • e
      • l
      • o
      • p
      • m
      • e
      • n
      • t
      • .

      Risks

        Patient & Prescribing Data

        Patients with recurrent ovarian cancer receiving Mirvetuximab Soravtansine.

        Close monitoring for ocular side effects is essential, especially for those treated for extended periods.

        Clinical Best Practices

        • additional_recommendation

        Related Resources & Content

        Original Source(s)

        Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery

        • by Jordyn F. Silverstein, Alexandra Smick, Edmund Tsui, Oladunni Alomaja, Bridget Johnson, Chi-Hong Tseng, Ritu Salani, Dennis J. Slamon, Dana M. Chase, Gottfried E. Konecny

        • May 21, 2026

        Related Content

        Correction to: Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center

        Beyond classical boundaries: rethinking ICU access in acute leukemia

        Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study